Quantcast

Crispus Attucks

Health Care News Back Issues - Click on an Issue to see Articles from that Issue

Health Care News
09/2002: State Legislative Update
Managing Editor’s note: Information here on legislative activity regarding MEHPA was provided by Andrew Schlafly, Esq., general counsel for the Association ... (read more)

09/2002: The Galen Report
The country dodged a bullet when the Senate rejected the latest compromise bill for a Medicare prescription drug benefit. The final bill was one of the ... (read more)

09/2002: The Pulse
Scott Holleran publishes “The Pulse,” a weekly email newsletter sort of like this one, on behalf of Americans for Free Choice in Medicine. His current edition ... (read more)

Colorado Health Insurance Market Evaporating
Colorado’s small group health insurance market displays all the symptoms of a patient in dire distress. While premiums and the ranks of the uninsured soar, ... (read more)

Congress Approves $100 Million for High-Risk Pools
The Trade Adjustment Assistance Act (TAAA), passed by the Senate on August 2 by a vote of 64-34, contains a little-known provision that could provide a ... (read more)

Congress Gets Hooked on Rx Drug Plans
Bidding wars over a Medicare prescription drug benefit are accelerating, with political leaders behaving as though they were in a high-stakes poker game ... (read more)

MEHPA Update: Most States Reject Law
A year ago this month, anthrax attacks sent shock waves from coast-to-coast and border-to-border as state health care officials tried to cope with potential ... (read more)

Micro-Management Failed Us in Vietnam ... Is Medicine Next?
For 35 years, Ron Glasser has pursued two passions. The Minneapolis physician has enjoyed a distinguished career as a pediatric nephrologist, or kidney ... (read more)

Other People’s Money
On Capitol Hill, members of Congress are continually increasing the price Americans pay for health care. They do this by giving away benefits and, in some ... (read more)

Patent Protection Law at Risk
Failing to pass a prescription drug benefit for seniors in July, the Senate offered consumers legislation that encourages cheaper generic alternatives to ... (read more)

Profits, Patents, and Seniors: A guide for policymakers
The U.S. House of Representatives passed Medicare prescription drug benefit legislation, only to have it defeated in the Senate. AARP—the nation’s largest ... (read more)

Reform the FDA, Not Patent Laws
The Senate’s recent passage of the Greater Access to Affordable Pharmaceuticals Act (GAAP) proves Senators are seeking an easy way around a complex issue. ... (read more)

Senate Rejects Yet Another Rx Plan
A Medicare prescription drug benefit is all but dead for this year’s Congressional session. The Senate defeated a scaled-back plan to help the nation’s ... (read more)

September 2002 Health Care News (pdf)
The September 2002 issue of Health Care News reports a potential breakthrough for free-market approaches to health care policy: Provisions in the Trade ... (read more)

State Drug Price Controls Backfire
Politicians in Washington, DC and state capitols across the country have claimed the remedy for high-priced prescription drugs is to be found in enacting ... (read more)

The Myths of Medical Monopoly and Monopsony
Two erroneous notions have long infected the debate about appropriate public policies for prescription drugs. The first is that patents protecting intellectual ... (read more)

What Are High-Risk Pools?
High-risk pools play an important role in a free-market health care system. They are state-chartered, nonprofit associations offering comprehensive health ... (read more)

Why Do Public Health Advocates Lie About the Risks of Smoking?
At the Northwestern train station in downtown Chicago, commuters are met with a billboard that reads: “Odds of dying in a car crash: 6,200 - 1; dying from ... (read more)

Why Price Controls Don’t Work
State efforts to rein in health care spending by imposing price controls on pharmaceutical manufacturers are not the first time price controls have been ... (read more)